SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-034454
Filing Date
2022-06-23
Accepted
2022-06-23 06:02:11
Documents
3
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea161950-6k_alteritytherap.htm 6-K 12357
2 REGULATORY APPROVAL TO PROCEED WITH PHASE 2 TRIAL IN ITALY ea161950ex99-1_alterity.htm EX-99.1 14934
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4265
  Complete submission text file 0001213900-22-034454.txt   34404
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 221033491
SIC: 2834 Pharmaceutical Preparations